Table 1. Patient demographics.
| Parameters | Total | PPV | Non-PPV |
| Gender | |||
| M | 14 | 6 | 8 |
| F | 9 | 1 | 8 |
| Ethnicity | |||
| White/any other white background | 4 | 0 | 4 |
| Asian/any other Asian background | 10 | 4 | 6 |
| Black/any other black background | 2 | 1 | 1 |
| Other/unknown | 7 | 2 | 5 |
| Diabetes control | |||
| Insulin | 3 | 1 | 2 |
| Tablets | 6 | 2 | 4 |
| Insulin+tablets | 11 | 4 | 7 |
| Unknown | 3 | 0 | 3 |
| PPV indication | |||
| ERM peel | 2 | 2 | N/A |
| VH | 4 | 4 | N/A |
| TRD | 1 | 1 | N/A |
| Previous PRP | 8 | 6 | 2 |
| Pre-Iluvien® maculopathy treatments | |||
| Intravitreal anti-VEGF | 11 | 2 | 9 |
| Intravitreal TA | 6 | 0 | 6 |
| Macular laser | 12 | 1 | 11 |
| Pre-Iluvien® OCT features | |||
| CME | 11 | 2 | 9 |
| Hyper-reflective epiretinal band | 12 | 4 | 8 |
| Intact ellipsoid | 9 | 2 | 7 |
| IOP lowering treatment | |||
| Pre-Iluvien® | 6 | 5 | 1 |
| Started after Iluvien® | 3 | 0 | 3 |
PPV: Pars plana vitrectomy; ERM: Epiretinal membrane; VH: Vitreous hemorrhage; TRD: Tractional retinal detachment; N/A: Not applicable; PRP: Panretinal laser photocoagulation; VEGF: Vascular endothelial growth factor; TA: Triamcinolone acetonide; OCT: Optical coherence tomography; CME: Cystoid macular edema; ELM: External limiting membrane; IOP: Intraocular pressure.